CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 137 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04357964
NCT04357964N/ACompleted

Beige Fat, Energy, and the Natriuretic Peptide System (ENDA-025-17S)

VA Office of Research and Development·observational·Posted Apr 22, 2020·Updated Aug 1, 2024

In Brief

An observational study for Obesity. Completed, enrolled 137 participants across 2 sites.

Detailed Summary

Obese individuals experience an increased risk of cardiovascular and metabolic diseases. Evidence from genetic studies indicate that the natriuretic peptide (NP) system may protect against these diseases. NP levels differ by obesity status and race has not been established in humans. Thus, the investigators propose a study in which will quantify adipose tissue gene expression and energy expenditure in states of NP deficiency in humans. The overarching postulate is that obese and black individuals have NP deficiencies that contribute to less beige adipose tissue and lower energy expenditure.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 22, 2020
Enrollment StartApr 13, 2020
Primary CompletionOct 31, 2022
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 6.2 years ago